Issued and Outstanding as of April 30, 2025
675,436,334
Unlimited number of common shares without par value
The following table outlines the maximum potential impact of share dilution upon full execution of outstanding convertible instruments as at the effective date of the MD&A – March 31, 2025.
| Column 1 | Number |
|---|---|
| Common shares outstanding | 675,436,334 |
| Outstanding share purchase options | 457,616 |
| Outstanding restricted share units | 645,507 |
| Outstanding share performance units | 6,227,320 |
| Full dilution impact on common shares outstanding | 682,766,777 |
Insider Shareholdings
Shareholdings by insiders can be found on the following websites: